Eli Share Price

Eli Share Price

NYSE: LLY | Mega Cap | Healthcare
$1,348.33
-$3.52 (-0.26%) Last updated on 21 Nov, 2026 | 03:07 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • Corporate Actions
  • About
  • Price history
  • Similar Stocks
  • FAQs

Eli Stock Performance

Open
$1,362.99
Prev. Close
$1,351.85
Circuit Range
N/A
Day Range
$1,341.88 - $1,371.70
Year Range
$850.64 - $1,474.71
Volume
1,41,660
Average Traded
$1,357.25

Eli Share Price Today

As of 21 November 2026, Eli Lilly & Co.'s share price is $1,348.33. The stock opened at $1,362.99, compared to its previous close of $1,351.85. During today's trading session, Eli Lilly & Co.'s share price traded between $1,341.88 and $1,371.70, with an average price of $1,356.79. Over the past 52 weeks, the stock has recorded a high of $1,474.71 and a low of $850.64. In terms of performance, Eli Lilly & Co.'s share price has risen by 22.02% over the last six months and is up 25.42% on a year-on-year basis.

Eli Share Price Chart

Line chart of the Eli price trend over the selected period. The price fell overall, ranging from 1342.71 to 1371.19, ending at 1348.10.
$1,341.88$1,371.70
L
Show Current Price
H

Eli Stock Fundamentals & Key Indicators

Market Cap
$1.21T
PE Ratio (TTM)
43.64
Dividend Yield
0.50%
EPS (TTM)
$30.96
Revenue (TTM)
$65.18B
Return On Equity (TTM)
68.49%
Profit Margin
31.67%
Debt to Equity
1.23
Quarterly Earnings Growth YoY
-2.86%

Eli Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$19.29$19.80$22.97$24.40
Net Profit$6.64$7.40$7.10$6.45
Net Profit Margin34.42%37.37%30.91%26.43%
Income ChangeN/A11.45%-4.05%-9.15%

Eli Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$28.54$34.12$45.04$65.18
Net Profit$6.24$5.24$10.59$20.64
Net Profit Margin21.86%15.36%23.51%31.67%
Income ChangeN/A-16.03%102.10%94.90%

Eli Balance Sheet

All figures in USD Billion

Particulars2025202420232022
Non Current Assets56.8545.9838.2831.46
Current Assets55.6332.7425.7318.03
Total Assets112.4878.7264.0149.49
Non Current Liabilities50.7136.0725.8521.58
Current Liabilities35.2328.3827.2917.14
Total Liabilities85.9464.4453.1438.71
Shareholders' Equity26.5414.2710.8610.78

Eli Cash Flow

Annually
Particulars2025202420232022
Operating (USD Billion)16.88.84.26.5
Investing (USD Billion)-11.0-9.3-7.2-2.6
Financing (USD Million)-2,213.01,230.03,496.0-5,406.7

Corporate Actions

Dividend
Ex-date: 13 Nov 2026

Dividend
Ex-date: 14 Aug 2026

Dividend
Ex-date: 15 May 2026

Dividend
Ex-date: 13 Feb 2026

Dividend
Ex-date: 14 Nov 2025

Dividend
Ex-date: 15 Aug 2025

Dividend
Ex-date: 16 May 2025

Dividend
Ex-date: 14 Feb 2025

Dividend
Ex-date: 15 Nov 2024

Dividend
Ex-date: 15 Aug 2024

Dividend
Ex-date: 15 May 2024

Dividend
Ex-date: 14 Feb 2024

About Eli

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio and Jaypirca for cancer; Mounjaro, Zepbound, Foundayo, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Eli Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1,399.33
$1,342.93
-5.23%
Oct 2026
$1,149.24
$1,417.06
+21.93%
Sep 2026
$1,184.81
$1,162.17
-1.15%
Aug 2026
$1,151.54
$1,175.64
+2.33%
Jul 2026
$1,211.52
$1,148.86
-4.21%
Jun 2026
$1,096.77
$1,199.36
+8.54%
May 2026
$947.49
$1,105.00
+18.20%
Apr 2026
$930.00
$934.86
+1.65%
Mar 2026
$1,046.80
$919.73
-12.62%
Feb 2026
$1,039.78
$1,052.58
+1.43%
Jan 2026
$1,071.36
$1,037.76
-3.47%
Dec 2025
$1,073.69
$1,075.11
+0.01%

Eli Share Price FAQs